Is it the authors' opinion that we largely rely on infectious agents to generate the regulatory B cells that contribute not only to recovery from exacerbation of autoimmune disease, but also to ...

这项发现为我们提供了一个全新的视角来评估免疫治疗的长期效果。通过检测患者肿瘤组织中前体耗竭性T细胞（Texp）的比例，我们或许能够更准确地预测他们未来复发的风险，从而为制定更个体化的治疗和随访策略提供依据。

Study reveals B cells suppress mutations during rapid division, enhancing immune response and offering critical insights for ...

People commonly refer to these as B cells and T cells. The job of T cells is to help the body kill cancer cells and control the immune response to foreign substances. They do this by destroying ...

Tolebrutinib was granted breakthrough therapy designation by the FDA based on positive results from the HERCULES phase 3 study in adults with non-relapsing secondary progressive MS ...

Financial Considerations Under the terms of the merger agreement, Sanofi will acquire DR-0201 through the acquisition of the Dren Bio affiliate Dren-0201 for an upfront payment of $600 million and ...

Her writing focuses on gene editing technology, cell and gene therapies, and the regulatory space. View Full Profile ... In an earlier study, the team used this technology to measure protein secretion ...

The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submission of tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis (nrSPMS) and to ...

Scientists hoping to treat immunodeficiencies using gene therapy have found a way to edit stem cells in mice without disrupting gene regulation. Kamal is a freelance science journalist based in the UK ...